Frontiers Effect of the serum 25-hydroxyvitamin D level on risk for short-term residual dizziness after successful repositioning in benign paroxysmal positional vertigo stratified by sex and onset age

ObjectiveA low serum 25-hydroxyvitamin D (25(OH)D) level is relevant to both the occurrence and recurrence of benign paroxysmal positional vertigo (BPPV). Ho

PDF) Mini-test of language for the neurologist: a protocol for topographic diagnosis in acute stroke patients according to language disorders

Residual Dizziness in Elderly Patients after Benign Paroxysmal Positional Vertigo

Frontiers Cortical metabolic characteristics of anti-leucine-rich glioma-inactivated 1 antibody encephalitis based on 18F-FDG PET

Common Geriatric Syndromes in Older Adults Nursing CE Course for

Audiology Research, Free Full-Text

Chemiluminescence immunoassay - List of Frontiers' open access articles

PDF) Association Between Serum Uric Acid Levels and Benign Paroxysmal Positional Vertigo: A Systematic Review and Meta-Analysis of Observational Studies

Nutrients, Free Full-Text

Frontiers Correlation Between Benign Paroxysmal Positional Vertigo and 25-hydroxyvitamin D

Frontiers TGF-β based risk model to predict the prognosis and immune features in glioblastoma

Frontiers in Neurology Neurological Biomarkers

Frontiers in Neurology

Frontiers Serum 25-hydroxyvitamin D is associated with stroke history in a reverse J-shape

Frontiers Effect of the serum 25-hydroxyvitamin D level on risk for short-term residual dizziness after successful repositioning in benign paroxysmal positional vertigo stratified by sex and onset age